As of Jun 30
| +0.17 / +2.13%|
The 5 analysts offering 12-month price forecasts for Inovio Pharmaceuticals Inc have a median target of 20.00, with a high estimate of 31.00 and a low estimate of 17.00. The median estimate represents a +145.10% increase from the last price of 8.16.
The current consensus among 5 polled investment analysts is to Buy stock in Inovio Pharmaceuticals Inc. This rating has held steady since June, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.